分化型甲状腺癌患者碘 131 治疗信息需求问卷的编制与验证（INQ-DTC）。
Development and validation of the information needs questionnaire for differentiated thyroid cancer patient with radioactive iodine therapy (INQ-DTC).
机构信息
School of Nursing and Health, Zhengzhou University, Zhengzhou, China.
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
出版信息
Nurs Open. 2022 May;9(3):1794-1804. doi: 10.1002/nop2.925. Epub 2021 May 18.
AIMS
This study aimed to develop and validate the psychometric properties of Information Needs Questionnaire for Differentiated Thyroid Cancer (INQ-DTC) in DTC patients with radioactive iodine (RAI) therapy.
DESIGN
Mixed methods.
METHODS
Using qualitative methods, we developed the initial questionnaire from a personal perspective of information needs of 15 patients with DTC. We used a formal Delphi consensus process to help assess the initial questionnaire and provide recommendations for its application. Totally, 230 DTC patients with RAI therapy were selected for the process of validation.
RESULTS
The final version of INQ-DTC contains 33 items. The total Cronbach's alpha coefficient was 0.945, the total split-half reliability was 0.822, and the test-retest value was 0.984 for the overall score. Exploratory factor analysis extracted 5 factors, which could explain 61.86% of the total variance. The Scale-level content validity index (S-CVI) was 0.928, and 0.929 for the item-level content validity index (I-CVI).
目的
本研究旨在为接受放射性碘（RAI）治疗的分化型甲状腺癌（DTC）患者开发和验证信息需求问卷（INQ-DTC）的心理测量特性。
设计
混合方法。
方法
采用定性方法，我们从 15 名 DTC 患者的个人信息需求角度出发，制定了初始问卷。我们使用正式的德尔菲共识过程来帮助评估初始问卷并提供其应用建议。共有 230 名接受 RAI 治疗的 DTC 患者参与了验证过程。
结果
INQ-DTC 的最终版本包含 33 个项目。总分的克朗巴赫系数为 0.945，总半分可靠性为 0.822，总体评分的重测值为 0.984。探索性因子分析提取了 5 个因子，可解释总方差的 61.86%。量表水平内容效度指数（S-CVI）为 0.928，项目水平内容效度指数（I-CVI）为 0.929。
Zotero 插件